3D Printing And Pharmaceutical Patent Infringement: Examining Liability For Digital Designs Used To Manufacture Patented Medicines
Shreyashi Singh, Bharati Vidyapeeth, New Law College, Pune
ABSTRACT
The increasing use of three-dimensional (3D) printing in pharmaceutical industry has sparked important legal concerns, especially regarding patent infringement. These concerns focus on whether the making, sharing, or distribution of digital designs that can be used to create patented medicines could lead to legal consequences. This article explores this issue in the context of the Indian Patents Act, 1970, with a specific look at Section 48. It examines the difference between digital designs and actual patented products, the possible responsibilities of third parties who support unauthorised production, and the shortcomings of the current legal system. By comparing Indian law with American and the European patent laws, the article investigates whether traditional patent principles are sufficient to handle the distinction between digital instructions and physical production. It suggests that sharing a digital file should not always be considered patent infringement. Instead, liability should be determined by the specific patent claims, the role of the digital file, the actions of the involved parties, and the relevant legal rules. The article supports a balanced approach that safeguards genuine pharmaceutical innovation while allowing for legal research, technological advancement, and access to essential medicines.
Keywords: Three-Dimensional (3D) Printing, Pharmaceutical Patent Infringement, Digital Designs, Computer-Aided Design (CAD) Files, Section 48, Indian Patents Act, 1970, Indirect Patent Infringement, Patent Liability, Comparative Patent Law, Access to Medicines.
